Royalty Pharma Soars 59% After Year’s Biggest U.S. IPO

Bookmark
(Bloomberg) -- Royalty Pharma Plc, a buyer of biopharmaceutical royalties, rose 59% in its trading debut after its upsized initial public offering raised $2.18 billion with shares priced at the top...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.